chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a female consumer with no pertinent medical history or drug reaction who on 06-JUN-2012 was vaccinated with ZOSTAVAX. There was no concomitant medication. On 07-JUN-2012 the patient noticed a 6 inch hot red spot. On 09-JUN-2012 (Saturday) the patient was in the emergency room with hives. The hcp diagnostics her with a local reaction with a secondary infection of cellulitis. The patient mentioned she was prescribed LEVAQUIN 500 mg and also had a horrible case of diarrhea. The patient mentioned it took about a week to feel better. No lab diagnostics study was performed. The patient sought medical attention. Follow up information as received from a licensed practical nurse refers to a 54 years old female patient with allergy to iodine, BIAXIN and MACRODANTIN. The patient was given ZOSTAVAX on 06-JUN-2012 at pharmacy. Two days later, on 08-JUN-2012, the patient developed cellulitis. She went to clinic and started on antibiotic. Next day, on 09-JUN-2012, she developed welts on upper arm and went to emergency room. The events gradually resolved over next week, in June 2012. The patient's outcome for diarrhea was unknown. The relatedness for secondary infection of cellulitis, horrible case of diarrhea and welts on upper arm is unknown for ZOSTAVAX. Additional information is not expected.
pregnant, first trimester, at time of booster, Vaginal  bleeding/miscarriage next day.
In Sept of 94, began feeling tired. Stubbed toe didn't heal for 6 months. In Sept of 96, quit smoking, feeling awful. In April 97, thyroid illness-myxedema coma. In following months joint pain. In Feb 98 see rheumatolgoist. RA confirmed 12/98. Still have rheumatoid arthritis.
Testicular itching; testicular redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Testicular itching) and ERYTHEMA (testicular redness) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PRURITUS (Testicular itching) and ERYTHEMA (testicular redness). At the time of the report, PRURITUS (Testicular itching) and ERYTHEMA (testicular redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
her heart was racing (170 bpm); fuzzy headed; peculiar musty scent coming off from her and her clothes; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in left arm on 28Feb2021 as 1st single dose for COVID-19 immunization. Patient's medical and concomitant medication history were not reported. The patient experienced her heart was racing (170 bpm), fuzzy headed and peculiar musty scent coming off from her and her clothes on 28Feb2021. After vaccination, within moments, patient heart was racing (170 bpm). Patient said that, pulse was fine but heart was racing. It made patient fuzzy headed. Because of this, patient had to call patient's son and give the medication for racing heart. Within 5 minutes, patient heart calmed down. This event made patient very much afraid about taking second dose of the vaccine. Patient was afraid that worse things may happen to patient with the second dose. Patient also said that the night after vaccination and also on the next several days, patient started to had a peculiar musty scent coming off from patient and patient's clothes. It had taken several days of bathing to wash of the scent on patient. The scent had already gone away. Patient had already talked with doctor who advised patient not to take the second dose of the vaccine. Patient's doctor also told that, if patient was pushed to take the second dose of the vaccine, then patient should have to take it in a hospital that would better assist in case worse reactions would occur. Patient wanted to know if Pfizer has recommendations about the second dose of the vaccine considering patient's situation. Therapeutic measures were taken as a result of her heart was racing. The patient underwent lab tests and procedures which included heart rate: 170 on 28Feb2021 Her heart was racing (170 bpm) , heart rate: heart was racing on 28Feb2021 Her heart was racing (170 bpm) , heart rate: calmed down on 28Feb2021 Within 5 minutes, her heart calmed down. The outcome of the event heart was racing (170 bpm) was resolving, fuzzy headed was unknown and peculiar musty scent coming off from patient and patient's clothes was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No adverse effects reported; received improperly stored VARIVAX; This spontaneous report was received from lead medical assistant refers to a 4 year old patient of unknown gender. The patient's medical history, concurrent conditions, historical drugs and drug reactions/allergies were not reported. Concomitant medication included sterile diluent. On 02-APR-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot # R023503 and expiry date 16-AUG-2020 (strength, dose, unit, route, anatomical location were not reported) for prophylaxis (product storage error). The vaccine was reconstituted with properly stored sterile diluent. The administered doses of the vaccines experienced temperature excursion from above 6 degree Fahrenheit (F) to 14 degree F (7.5 degree F) for five minutes. No previous temperature excursion was reported. The call was due to digital data logger. No adverse effects were reported. No product quality complaint (PQC) was involved.  This is one of several reports received from the same reporter.
had to leave work/unable to return to work; upset stomach; joint pain; fever up to 103 degrees F; chills; headache; nausea; muscle ache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (had to leave work/unable to return to work), ABDOMINAL DISCOMFORT (upset stomach), ARTHRALGIA (joint pain), PYREXIA (fever up to 103 degrees F) and CHILLS (chills) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced FEELING ABNORMAL (had to leave work/unable to return to work), ABDOMINAL DISCOMFORT (upset stomach), ARTHRALGIA (joint pain), PYREXIA (fever up to 103 degrees F), CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), MYALGIA (muscle ache) and FATIGUE (fatigue). The patient was treated with NAPROXEN at a dose of 500 milligram,moved up to 1000 mg every 8 hours. At the time of the report, FEELING ABNORMAL (had to leave work/unable to return to work), ABDOMINAL DISCOMFORT (upset stomach), ARTHRALGIA (joint pain), PYREXIA (fever up to 103 degrees F), CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), MYALGIA (muscle ache) and FATIGUE (fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 103 (High) fever up to 103 degrees F. In April 2021, Body temperature: 101 (Low) fever had gone done to 101 degrees F and 97 (normal) Today her temp is 97 degrees F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was used.
This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with M-M-R II HSA (dosage, concentration, route and lot number unknown). On an unknown date the patient had titers drawn. The Rubella and Mumps titers came back as positive however the Measles results were equivocal. Physician was unsure if the patient had received both required MMR vaccines as a younger person. No vaccination documentation was provided to the physician. No adverse effect reported. The patient didn't seek for medical attention. The outcome of the event was reported as unknown. Additional information has been requested.
Shortly after immunization, she reports that she experienced severe pain. In the same day, she noticed her skin started to turn red and feel hot to touch around the area of the shot. She came in to the pharmacy today to show me. Her left arm is red from the shoulder down to her elbow and about 4 inches in width.
This spontaneous report was received from a registered nurse refers to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On unspecified dates, the patients were vaccinated with improperly stored M-M-R II (lot # L012482, expiry date 10-APR-2017, dose, strength, dose number, vaccination site, route not provided). The temperature excursions were reported as 1.6 C for 39 minutes on 09-AUG-2016, 0.6 C for 1 hour 40 minutes on 10-AUG-2016, 1.5 C for 55 minutes on 11-AUG-2016, 1.5 C for 1 hour 7 minutes on 28-AUG-2016. No adverse effect were reported. Product quality complaint(PQC) was not involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Called on 12/14/00 to report that 45 minutes, post vax, on 12/15/00, pt experienced an episode of vertigo, feeling warm and perspiring, momentarily, with weakness and fatigue for 1 hour following episode.
Pt vacc. /w DTP/OPV developed fever to maximum 100, mild irritability x3d. Pt then found dead in crib on day 3.
Itchy Rash at injection site and underarms starting 6 days after injection.  Started 3/24
42yo F nurse recd primary smpx vaccine on 10 Mar 2017, in preparation for becoming a vaccine administrator. On 26 Mar, she first noticed itchy red papules on hands and feet. No fever, CP, or other systemic sxms, but itching and discomfort are impairing her activity. Additional information faxed with VAERS report, including photos. No history of having Eczema or Psoriasis. Received the Smallpox vaccine on 10MAR2017. On Monday, 27MAR2017 at 1100, I noticed 3 small bumps that I thought were the beginnings of palmar warts on my right palm. By 1300, I found 4 fluid filled bumps on my right index finger. By 1400, the soles of both my feet were itching tremendously. By 1600, both my thighs were itching and had broken out in hives. I applied Triamcinolone cream and CALMOSEPTINE ointment as directed by the Physician I saw earlier in the day. Tuesday, 28MAR2017, I noticed that the number of fluid filled bumps on my right hand had increased to 28 and I had 4 small bumps now on my left hand. Throughout the day the number of bumps on my left hand increased. My feet had small pink spots on the soles and were very itchy. My thighs still have raised bumps on them but not fluid filled like my hands, nor pink spots like my feet, more like itchy goosebumps. Wednesday, 29MAR2017, the number of fluid filled bumps on my hands seems to have stabilized at 42 on the right and 37 on the left, continue to be itchy and somewhat painful if bumped. The soles and sides of both my feet are covered with small pink spots; some you can see are fluid filled. My thighs have calmed down some with the use of Triamcinolone.
Received vaccines-that evening developed a red, raised, urticarial rash on face/arms/trunk/legs requiring Prednisone and antihistamines
Patient did not have any adverse events or effects from taking the shot.  The shot was expired-patient was contacted and they had no symptoms . They did not wish to come for a follow up shot as they were originally taking it for travel, but decided not to go.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. On 08-OCT-2015, the patient was vaccinated with the first dose in the HPV series with GARDASIL (dose, route and lot # not reported) and on 15-DEC-2015, the patient received the second dose with GARDASIL (route and lot# not reported). No adverse effect was reported. Additional information has been requested.
intermittent fever; diarrhea; chills; nausea; This is spontaneous report from a non-contactable other health professional. An adult female patient (occupation: Nurse, not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), intramuscularly at the age of 36-year-old (age at the time of vaccination) on 28Dec2020 at single dose at left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that 2 days later (30Dec2020): diarrhea, chills, nausea, intermittent fever. The events were non-serious per the reporter. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was unknown.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Patient was concerned that overnight after the vaccine he woke up shaking. Unable to sleep. Was concerned about interaction with Ozempic. He was able to nap the following day and symptoms resolved on their own.
Patient received High Dose influenza vaccine (FLUZONE HD) on 9/16/15; called 9/18/15 to report development of large hard lump the size of her palm at injection site, rash on underside of arm, and warmth with swelling thru-out upper arm. She does not report pain.
Developed cellulitis in RA < quarter size. 2/8/06 Dad called son has cellulitis where Pediarix was given on 1/11/06 given antibiotics info given to Dr. 2/13/06 Spoke with LPN, she asked me to call dad and find out particulars. Spoke with dad, states son had redness and swelling the day of the inj. They took him to see Dr 1 week later and was told it was cellulitis but not placed on antibiotic. Dad states area not any bigger. Will contact Dr to see what antibiotic he was placed on. Vaers report will be filed.
arm pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Oct-2021 and was forwarded to Moderna on 11-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia, Neuropathy, Sciatica and Acid reflux (esophageal). Concomitant products included GABAPENTIN, VALACYCLOVIR [VALACICLOVIR] and OMEPRAZOLE (ZEGERID [OMEPRAZOLE]) for Acid reflux (esophageal), ALPRAZOLAM, PRAVASTATIN, METOPROLOL, NALTREXONE, ALPRAZOLAM (XANAX) and VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for an unknown indication.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced PAIN IN EXTREMITY (arm pain). In June 2021, PAIN IN EXTREMITY (arm pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-349041 (Patient Link).
Excessive loss of hair. It started around 4 days after vaccine and now I'm afraid to even wash or brush my hair. It's falling off in clumps. This is not the normal amount one loses when you brush. I'm talking, I can't stop crying every time I run my fingers through my head and clumps of hair just fall off.  My husband ran to the bathroom cause he heard me screaming and he was horrified at what he saw. There was so much hair on the tub floor that it looked like I was giving myself a haircut. At the rate is falling, if it continues, I don't know if I will have much hair left, if any, in a month or so.
A report has been received from a Health Professional concerning a 1 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient experienced inadvertently administered FLUMIST QUADRIVALENT to a 15 month old which started on 27-Oct-2014. The outcome of the event of inadvertently administered FLUMIST QUADRIVALENT to a 15 month old is unknown. The report was considered to be non-serious.
I received the flu shot on 10/02/09. I woke up the next day with a painful and swollen lymph node on the right side of my neck.
A lot of body pain, chills, nausea, a great desire to cry, prick sensation in various parts of the body, fever once, neck very tense and with prick. Constant headache. Weakness, dizziness
The day after the shot he was running around outside and took his shirt off. His arm had about a four inch circle that was swollen, hot and red. I drew a circle around it and gave him Benadryl. The following morning, the circle had grown to about 6" and his arm was more swollen. I called the advice nurse. By the time I spoke with the doctor, the circle had grown another 1/2". From his shoulder to below his elbow is hot, red, swollen and hard.
After the shot 30 days later paralyzed from the neck down which they diagnosed as Guillain Barre from the flu shot (and my case wasn't reported).
CDC Reports: 2 mo infant received DTP/OPV on 27FEB90 and died 3MAR90.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. On 19-JUN-2015, the patient was vaccinated with (Oka/Merck) VARIVAX (lot#L001326, expiration date: 13-JAN-2017; dose, route of administration and anatomical location were not reported) that was improperly stored. No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
Shooting; burning sensation; nerve pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 5 year-old male patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 01Dec2021 08:00 (Lot number: fk5818) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (Dose Number: 1, Batch/Lot No: ik5127, Vaccine Administration Time: 08:30 AM), administration date: 10Nov2021, when the patient was 5 years old, for Covid-19 Immunization.  The following information was reported: PAIN (non-serious) with onset 01Dec2021 19:00, outcome "not recovered", described as "Shooting"; BURNING SENSATION (non-serious) with onset 01Dec2021 19:00, outcome "not recovered", described as "burning sensation"; NEURALGIA (non-serious) with onset 01Dec2021 19:00, outcome "not recovered", described as "nerve pain".  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Reported events included shooting, stabbing or burning sensation. It is presumably nerve pain. The (withheld) mon had similar pans but they stopped in 3 days after vaccination and (withheld) still has them 23 days after the second vaccination and they intensify. The patient was neither diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination.  Follow-up attempts are completed. No further information is expected.
Extreme abdominal pain, vomitting, diarrhea, slight fever, cold sweats, weakness
COVID-19 Vaccine Adverse Reaction:       75-year-old male with a past medical history of CAD status post CABG, hypertension, diverticular rupture s/p colectomy and rotator cuff tear s/p repair and re injury of his shoulder, he is not able to raise his shoulder above his head at baseline. Patient presents to ED complaining of right shoulder pain and swelling. He received a COVID vaccine on 02/02/2021 after which he developed mild fatigue and chills the day after and pain in his right shoulder.  Swelling of his right shoulder has gotten progressively worse. He was seen by an APN 3 days ago and she recommended follow-up if he gets worse.  Overnight he became more swollen and warm to palpation and that when he decided to come to the ED. Denies fever, chills, night sweats, no chest pain no dizziness or lightheadedness, no numbness or tingling sensation.   No current facility-administered medications for this encounter. Musculoskeletal:        General: Swelling present. No tenderness or edema.     Cervical back: Normal range of motion and neck supple. No rigidity or tenderness.     Comments: Right shoulder, decreased range of motion but that is his baseline from past injuries to his rotator cuff muscles, fluid collection palpated in the right shoulder, fluctuating, not warm not tender to palpation. Small amount of erythema noted around his previous injection site.   Adverse reaction to vaccine, sequela Diagnosis management comments:  75-year-old male with past medical history of CAD status post CABG, hypertension, diverticular rupture s/p colectomy and rotator cuff tear s/p repair and re injury of his shoulder, he is not able to raise his shoulder above his head at baseline. Patient presents to ED complaining of right shoulder pain and swelling after receiving a Covid vaccination.    Denies fever, chills, night sweats, no chest pain no dizziness or lightheadedness, no numbness or tingling sensation. X-ray of the right shoulder was obtained, showing chronic degenerative disease changes and a previous rotator cuff repair. Patient had no physical exam findings concerning for a septic arthritis, as he had no pain to his shoulder joint. Procalcitonin was wnl. Decision was made to start patient on an empiric course of antibiotics for a possible overlying cellulitis given the erythema to his skin.  Patient sent home with pain medications and ice cold packs and he was instructed to come back if he has any red flags.  He will have an appointment with his PCP to decide where is he going to receive his next dose of moderna COVID vaccine.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: AMLODIPINE; ATORVASTATIN; MELOXICAM; OMEPRAZOLE; VITAMIN D [COLECALCIFEROL]. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03Jul2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received Paxlovid from 17Jun2022 to 22Jun2022. Clinical course: Concomitant medication also included Multi vitamin.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.